ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9500
+0.0400 (4.40%)
Nov 16, 2026, 2:33 PM EST - Market open
ABVC BioPharma Employees
As of December 31, 2025, ABVC BioPharma had 19 total employees, including 16 full-time and 3 part-time employees. The number of employees did not change compared to the previous year. That makes ABVC BioPharma the 38,547th largest employer in the world and 5,535th in the United States.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$206,046
Market Cap
24.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2024 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2023 | 19 | -4 | -17.39% | 16 | 3 |
| Dec 31, 2022 | 23 | -7 | -23.33% | 19 | 4 |
| Dec 31, 2021 | 30 | -4 | -11.76% | 28 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| Filana Therapeutics | 20 |
| Edesa Biotech | 17 |
| CervoMed | 15 |
| TransCode Therapeutics | 12 |
| Lite Strategy | 5 |
ABVC News
- 4 days ago - ABVC BioPharma Registration statement: Registration filing - Filings
- 6 days ago - ABVC BioPharma Quarterly report: Q3 2026 - Filings
- 14 days ago - WallachBeth Capital Announces ABVC BioPharma Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of $3.39 Million - PRNewsWire
- 6 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 2 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 2 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 3 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 3 months ago - ABVC BioPharma Quarterly report: Q2 2026 - Filings